Description and <i>In silico</i> ADME Studies of US-FDA Approved Drugs orDrugs under Clinical Trial which Violate the Lipinski’s Rule of 5
Niyatha Lohit(Central University of Punjab), Pradeep Kumar(Central University of Punjab), Adarsh Kumar(Central University of Punjab), Harshwardhan Singh(Central University of Punjab), Jagat Pal Yadav(Sam Higginbottom Institute of Agriculture), Ankit Kumar Singh(Central University of Punjab), Kuldeep Singh(National Institute of Pharmaceutical Education and Research)
Cited by 52
Related Papers
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
|Pharmaceuticals|2023|317
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
|Pharmaceuticals|2022|190
Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry
|Intelligent Pharmacy|2024|82
Metal Complexes in Cancer Treatment: Journey So Far
|Chemistry & Biodiversity|2023|74
Phytoconstituents as modulators of NF-κB signalling: Investigating therapeutic potential for diabetic wound healing
|Biomedicine & Pharmacotherapy|2024|74